Management PresentationJune 2015

• Genoa Overview

• Specialty Mental Health Market

• Financial Review

1

Agenda

One of the largest and most experienced global private equity firms

$31.4 billion in assets under management across developed and emerging markets

Discrete sector focus across 5 five global sector teams, including Business & Financial Services; Healthcare; Industrial; Retail, Consumer & Leisure; and Technology, Media & Telecom

Advent recapitalized Genoa, a QoL Healthcare Company on April 30, 2015

Nautic Partners remains minority investor

Overview

2

Advent Sponsor Overview

Company Overview

LARGEST NATIONWIDE PROVIDER OF SPECIALTY MENTAL HEALTH PHARMACY

SERVICES

Basic Facts

3

Largest nationwide provider of specialty mental health pharmacy services for community mental health centers (“CMHCs”)

Founded in 2000

Headquartered in Seattle, WA

252 Pharmacies in 36 states

Serves approximately 350,000 patients annually

Opened an average of 34 de novo pharmacies annually over the past three years, 2015 plan of 40

Projected Revenue of approximately $900 million

Highly Experienced Management Team

John FigueroaChief Executive Officer

25 Joined Genoa in July 2014 as Chief Executive Officer Previously served the dual roles of CEO of Apria Healthcare Group Inc. and Coram LLC, as well as

CEO and Director of Omnicare Previously served as President of McKesson Corporation’s US Pharmaceutical Group from 2006-2010

Victor Breed Chief Financial Officer

16 Joined Genoa in October 2006 Previously the EVP of Finance and Operations for medical device company, ClearMedical, Inc.

Mark PetersonEVP of Strategy and Corporate Development

24 Joined Genoa in 2003 Prior to Genoa, served as Senior Vice President of Marketing and Data Services with HealthNexis LLC,

as well as a Vice President of Sales for the economic and outcomes research division at Ingenix, a unit of United HealthGroup

Dave VucurevichChief Operating Officer

33 Joined Genoa in 2014 as Chief Operating Officer Prior to joining Genoa, served as President and COO of Prasco Laboratories, as well as holding senior

leadership positions at Rite Aid and Albertsons

Kathleen McGuanChief Compliance Officer

25 Joined Genoa in 2014 as Chief Compliance Officer Prior to joining Genoa, served as a partner in the Washington D.C. office of Reed Smith, LLP, as well

as Associate General Counsel for the U.S. Department of Health and Human Services and Chief Counsel for Centers for Medicare and Medicaid Services (CMS)

Vicki OlafsonVP of Human Resources

16 Joined Genoa in November of 2010 Previously served as a Human Resources Manager for Vertafore

John McConnellChief Information Officer

24 Joined Genoa in July 2012 as the Senior Information Systems Program Manager and transitioned into the Chief Information Officer in February 2013

Before Genoa, served as a Senior Business Intelligence Consultant and Product Manager at Extended Results, Inc.

Name Years of Experience Background

4

Examples of Genoa Pharmacy

• Contract directly with community mental health centers (“CMHCs”) to lease space and provide on-site pharmacy and related services

• Compelling value proposition for patients, clinicians, and payors, improved medication compliance, lower total cost of care

• Majority of revenue from patients who suffer from one or more serious mental conditions, insured through Medicare Part D and Medicaid

• Genoa-QoL has grown from <10 pharmacies in 2005 to >240 pharmacies currently including adding an average of 30+ pharmacies annually over the past 3 years

• Over 40% of the existing pharmacy base less than 3 years old. Significant embedded growth opportunity as pharmacies mature

Overview

Business Overview

(1)

5

Genoa pharmacies offer compelling benefits to all constituents

Compelling Value Proposition for All Key Constituents

Clinicians / Prescribers

Increases accuracy and consistency in tracking patient medication therapy progress and gaps

On‐site pharmacist streamlines prescription filling and reconciliation process

Reporting provides actionable information to clinicians and case managers

Allows clinicians and case managers to remain HIPAA‐compliant, provides easy access to the pharmacy system and increases medication pick‐up rates

Genoa handles the prior authorization, reducing clinician workload

Clinical management

Reporting

Patients Personal relationships with pharmacists improve patients' experience

Convenient on-site pharmacies improves medication adherence

− Simplifies the experience of managing medication regimens

− Enhances treatment success levels

Mail and additional delivery options reduce transportation issues

Prescription fulfillment monitoring and reminders

Perforated blister packing system that allows a patient to tear off a day’s or week’s doses. Each bubble is color-coded and includes specific information on how the medication should be taken

The Company can fill non-behavioral scripts as well

Convenience

Expertise

Counseling

Payors Work with patients on prior authorizations and general assistance with reimbursement

Increases behavioral and physical medication utilization and adherence which reduces inpatient hospital stays and total cost of patient care

Decreases waste and increases efficiency

Adherence

Quality

Waste reduction

Facilities Supports and complements the clinical care model

Eases the workload of organizational staff

Increases compliance by leveraging centralized compliance infrastructure

Compliance

Clinical focus

Cost reductions

6

Comprehensive Service Offerings

GENOA PHARMACISTS PROVIDE A LEVEL OF CARE THAT IS UNAVAILABLE AT A

TRADITIONAL PHARMACY

• Medication Therapy Management• Payor Assistance and PAP Enrollment

• Reporting

• Specialty Packaging• Clozapine Monitoring and Phlebotomy

• Call Center

7

Geographic Footprint

Pharmacies by Year

252 pharmacies in 36 states

• Generally located within mental health facilities in space leased from partners, typically CMHCs.

• Recent legislation and regulatory changes may open up additional states

3 5 6 9

40

62

8297

118

141

173

205

241252

0

50

100

150

200

250

2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 YTD2015

NATIONAL MENTAL HEALTH NETWORK WITH UNSURPASSED SCALE AND SIZE

Locations

8

As of May 2015, Genoa operates 252 pharmacies across 36 states

Leading Geographic Footprint

9

Where Does Genoa Rank?

Rank CompanyOpen

Pharmacies

1 Walgreens 8,210

2 CVS Caremark 7,710

3 Rite Aid 4,587

4 Walmart 4,176

5 Kroger 2,109

6 Target 1,749

7 Safeway 1,079

8 Publix 900

9 K-Mart 840

10 Albertsons 780

11 Costco 643

12 Ahold 586

13 Sam’s Club 581

14 Medicine Shoppe 570

15 BI-LO Winn Dixie 550

16 Fred’s 355

17 Shop-Ko 274

18Genoa, a QoL Healthcare

Company252

19 H-E-B 240

20 Hy-Vee 238

• Top 20 Retail Pharmacies according to National Association of Chain Drug Stores 2014-2015

Chain Member Fact Book*

10

Specialty Mental Health Market

11

Market Overview – Mental Health

• 1:4 adults, or ~61.5m Americans, experiences mental illness in any given year(1)

• 1:17 adults, or ~13.6m Americans, lives with a serious mental illness(1)

• In 2014, there were nearly 119 medicines in development to treat mental illness, including 36 for schizophrenia(2)

• In 2013, 29.5 million adults used prescription drugs for mental health treatment and a mental health patient is dispensed on average 48 prescriptions a year, compared to the total population average of 12 per year

• Market-wide shift towards outpatient care driven by:

– Emphasis on lowering cost

– Move towards a recovery based care model

The Mental Health Market Comprises 7% of the total U.S. Pharmaceutical Market

7%

93%

$23.8bn mental health market

Total $329 billion U.S. pharmaceutical market

(1) The National Alliance on Mental Illness Fact Sheet.(2) Medicines in Development, Mental Illnesses 2014 Report presented by America’s Biopharmaceutical Research Companies.

MARKET DEMAND CREATES SIGNIFICANT OPPORTUNITIES INTHE MENTAL HEALTH

SPACE

2013

Percentage of Adults with Past Year Serious Mental Illness who Used Various Services

Prescription Medicine, 62%

Outpatient Services, 47%

Inpatient Services, 8%

0%

25%

50%

75%

100%

Prescription Medicine Outpatient Services Inpatient Services

12

Favorable Legislative Environment

• The Mental Health Parity and Addiction Equity Act of 2008 provides for equal coverage between psychiatric or mental health services and physical medical health services(1)

• Several states have adopted parity laws requiring private insurance policies to have the same deductibles, number of office visits, inpatient visits and co-payments for mental health disorders as for other illnesses

Mental HealthParity Legislation

Patient Protection and Affordable Care

Act

HealthcareReform will Spur

Revenues

• Enables most people who are now uninsured to get insurance through an insurance exchange, resulting in healthcare coverage for over 90% of Americans(1)

• Significantly expands options for affordable coverage through Medicaid expansion

• Reform is expected to provide more Americans with insurance and bring mental health and substance abuse coverage on par with that of medical and surgical services

• Healthcare exchanges will be subject to the Federal Mental Health Parity Law resulting in more individuals having comparable coverage for mental health

(1) IBISWorld report – “Mental Health & Substance Abuse Centers in the US”, May 2011.

FAVORABLE CHANGES IN REGULATORY ENVIRONMENT TO SPUR ADDITIONAL

GROWTH

13

CMHCs are typically not‐for‐profit organizations established under the Community Mental Health Act of 1963 to provide community‐based mental health care services as an alternative to institutionalization

They provide specialized mental health services across a continuum of care settings including: residential homes, crisis centers and outpatient clinics

Patients treated at CMHCs typically suffer from severe chronic conditions such as:

Schizophrenia

Acute Bipolar Disorder

Severe Depression

These conditions require a significant amount of expertise not available in less specialized settings

Primary means of payment are Medicare and Medicaid

Federal funding for community mental health centers has been stable to positive over the past 6 years and is expected to continue

Additionally, funding from other sources, such as state budgets, has been stable

CMHC Overview

(1)

14

Financial Review

15

Historical Financial Summary

Revenue ($Millions)

PROVEN TRACK RECORD OF GROWTH AND OPERATIONAL EFFICIENCY

$317

$417

$451

$575

$732

2010 2011 2012 2013 2014

Projected Revenue approx. $900 Million

16

Historical Financial Summary

Free Cash Flow and Free Cash Flow Conversion ($Millions)

PROVEN TRACK RECORD OF GROWTH AND STRONG FREE CASH FLOW CONVERSION

17

86%

90% 88%

95%

97%

2010 2011 2012 2013 2014

FCF FCF Conversion

• Low capital expenditure requirements